These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 17191163)

  • 1. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC; Bosarge JR; Quin LR; McDaniel LS
    Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
    Ricci S; Janulczyk R; Gerlini A; Braione V; Colomba L; Iannelli F; Chiavolini D; Oggioni MR; Björck L; Pozzi G
    Vaccine; 2011 Oct; 29(46):8241-9. PubMed ID: 21911026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
    Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
    Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of lactococcal GEM-based pneumococcal vaccines.
    Audouy SA; van Selm S; van Roosmalen ML; Post E; Kanninga R; Neef J; Estevão S; Nieuwenhuis EE; Adrian PV; Leenhouts K; Hermans PW
    Vaccine; 2007 Mar; 25(13):2497-506. PubMed ID: 17081660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
    Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
    Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.
    Medina M; Villena J; Salva S; Vintiñi E; Langella P; Alvarez S
    Microbiol Immunol; 2008 Aug; 52(8):399-409. PubMed ID: 18667039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
    He X; McDaniel LS
    FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
    Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.
    Cui Y; Zhang X; Gong Y; Niu S; Yin N; Yao R; Xu W; Li D; Wang H; He Y; Cao J; Yin Y
    Vaccine; 2011 Feb; 29(9):1736-44. PubMed ID: 21238570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH
    J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.
    Hotomi M; Kono M; Hollingshead SK; Briles DE; Yamanaka N
    Adv Otorhinolaryngol; 2011; 72():121-5. PubMed ID: 21865708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
    Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT; Benjamin WH; Hollingshead SK; Briles DE
    Vaccine; 2005 Jul; 23(33):4257-62. PubMed ID: 16005736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.